Evaluation of predictors of rejection and infection in cyclosporine-treated solid organ transplant recipients.
Grinde
S
S
Immunology Center, Loma Linda University and Medical Center, California 92354-2870.
Fagoaga
O
O
Thorpe
R
R
Wahlstrom
E
E
Bailey
L
L
Nehlsen-Cannarella
S
S
D015703:Antigens, CD / Q000097:blood; D003141:Communicable Diseases / Q000175:diagnosis* / Q000453:epidemiology; D016572:Cyclosporine / Q000627:therapeutic use*; D016002:Discriminant Analysis; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008991:Monitoring, Physiologic; D011237:Predictive Value of Tests; D011379:Prognosis; D015375:Receptors, Interleukin-2 / Q000032:analysis; D012189:Retrospective Studies; D013997:Time Factors; D014181:Transplantation Immunology; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7 / Q000097:blood
D015703:Antigens, CD; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7; D016572:Cyclosporine